1Wk·

Sale TransMedics Group

$TMDX (+4.52%)


After careful consideration, I have decided to sell the small share $TMDX (+4.52%) until there is more clarity here. Above all, I also wanted to free up capital for possible additional purchases at $AMD (+1.62%) / $NU (+3.61%) / $IREN (+1.91%) to be able to make additional purchases.


Not that I necessarily believe in the correctness of the short report, but this situation makes it the easiest decision to liquidate my position.

13.01
Transmedics Grp logo
Sold x34 at €62.86
€2,137.24
3.57%
9
11 Comments

profile image
oh what a pity
I am waiting for the reaction of the company
2
profile image
@Memo0606 also a good decision, it may be that it shoots up again immediately, I just wanted to have capital to be able to buy other stocks because I can't free up anything at the moment. ✌️ I am otherwise 100% invested.
1
profile image
@BamBamInvest do you see more potential and a good time to enter the market at $IREN?
1
profile image
@Memo0606 difficult as it is still too dependent on $BTC, but not too expensive in terms of valuation and I like the combination of alternative energy, data centers, Bitcoin mining, AI, etc. Many trends play a role here. However, I am still invested very small to be able to buy more.
1
Have you ever looked into $CORZQ in this context? And if so, where do you see the advantages of $IREN, apart from the fact that they are also traded in Germany!
1
profile image
@Multibagger no, I haven't done that yet, but $IREN is also very well positioned in terms of the surfaces it has.
profile image
Yes, well, I think most people don't have much capital on the side right now. And they are all in because they were expecting a strong January.
2
profile image
I guess you don't have to sleep without a bed after all 😝😁✌️
1
profile image
@Aktienhauptmeister Hahahaha right, at least for the time being.
1
profile image
Do you think $AMD could still fall below 100?
profile image
@Max095 Anything is possible, especially with poor earnings or if the market falls.
1
Join the conversation